A Study to Evaluate the Effect of Lorcaserin Hydrochloride on Smoking Cessation

PHASE2CompletedINTERVENTIONAL
Enrollment

603

Participants

Timeline

Start Date

March 31, 2014

Primary Completion Date

November 30, 2014

Study Completion Date

November 30, 2014

Conditions
Smoking Cessation
Interventions
DRUG

APD356-lorcaserin hydrochloride

DRUG

Placebo

Trial Locations (31)

11229

Integrative Clinical Trials, Brooklyn

19046

Clinical Trial Center, Jenkintown

27103

PMG Research Inc., Winston-Salem

27609

PMG Research Inc., Raleigh

27705

Duke University, Durham

28401

PMG Research Inc., Wilmington

29464

Coastal Carolina Research Center, Mt. Pleasant

30030

iResearch Atlanta, Decatur

32256

Clinical Neuroscience Solutions, Inc., Jacksonville

32720

Avail Clinical Research, DeLand

32765

Compass Research East, Oviedo

32806

Clinical Neuroscience Solutions, Inc., Orlando

Compass Research, Orlando

33606

Meridien Research, Tampa

33805

Meridien Research, Lakeland

34748

Compass Research East, Leesburg

37203

Clinical Research Associates, Inc., Nashville

38119

Clinical Neuroscience Solutions, Inc., Memphis

44718

Neurobehavioral Clinical Research, Canton

45417

Midwest Clinical Research Center, Dayton

64114

Center for Pharmaceutical Research, Kansas City

68114

Quality Clinical Research Inc., Omaha

75230

KRK Medical Research, Dallas

78705

Benchmark Research, Austin

89104

Clinical Research Center of Nevada, Las Vegas

90720

Pharmacology Research Institute, Los Alamitos

91316

Pharmacology Research Institute, Encino

92025

Synergy Escondido, Escondido

92270

Desert Valley Research, Rancho Mirage

92660

Pharmacology Research Institute, Newport Beach

02865

Lincoln Research, Lincoln

Sponsors
All Listed Sponsors
lead

Arena Pharmaceuticals

INDUSTRY

NCT02044874 - A Study to Evaluate the Effect of Lorcaserin Hydrochloride on Smoking Cessation | Biotech Hunter | Biotech Hunter